FDA Inspection 996812 — Fulton D'Souza, MD
The FDA completed an inspection of Fulton D'Souza, MD on Nov 16, 2016 in Bangalore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Bangalore (India)
Additional Details
Clinical Investigator (CI)